Skincell Mole & Skin Corrector Serum — Class II drug recall D-0008-2023
Terminated recall by Justified Laboratories, reported 2022-10-19, distributed in PR. Marketed Without An Approved NDA/ANDA; Unapproved new drug
| Recall number | D-0008-2023 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Justified Laboratories, Arlington, TX, United States |
| Recall initiated | 2022-09-09 |
| Classified | 2022-10-07 |
| Reported by FDA | 2022-10-19 |
| Terminated | 2023-08-10 |
| Distributed | PR |
| Countries outside the US | CA |
| Reason classes | unapproved product |
| UPC / GTIN / UDI-DI | 00810077532201 |
Product
Skincell Mole & Skin Corrector Serum, 1 fl. oz./30 mL jars, Distributed By: Justified Laboratoires, Arlington, TX 76011 USA UPC 8 10077 53220 1
Reason for recall
Marketed Without An Approved NDA/ANDA; Unapproved new drug
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0008-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.